Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

VRDNVRDN
7 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in VIRIDIAN THERAPEUTICS INC

GOLDMAN SACHS GROUP INC holds 1.7M shares of VRDN (VIRIDIAN THERAPEUTICS INC), worth $31.1M as of 2026-Q2. The position was increased (+6.2% shares). VRDN represents 0.0% of GOLDMAN SACHS GROUP INC's portfolio.

Current Value

$31.1M

Current Shares

1.7M

Total Value Change

+$13.4M

Total Shares Change

+771,210

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1.7M
+6.2%
$31.1M0.0%$18.37
31
2026-Q1
Increased
1.6M
+25.9%
$31.1M0.0%$29.32
36
2025-Q4
Increased
1.3M
+65.3%
$39.3M0.0%$31.02
43
2025-Q3
Decreased
764,562
-15.0%
$16.5M0.0%$21.61
0
2025-Q2
Decreased
899,825
-26.9%
$12.6M0.0%$14.33
0
2025-Q1
Increased
1.2M
+33.8%
$16.6M0.0%$14.44
36
2024-Q4
New
920,094
-
$17.6M0.0%$19.54
39

Other major holders of VRDN: FMR LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used